These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 1422189

  • 21. Synthetic domains of cystatins linked to enkephalins are novel inhibitors of brain cathepsins L/B.
    Marks N, Berg MJ, Makofske RC, Danho W.
    Peptides; 1990; 11(4):679-82. PubMed ID: 2235677
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Regulation of the activity of lysosomal cysteine proteinases by pH-induced inactivation and/or endogenous protein inhibitors, cystatins.
    Turk B, Bieth JG, Björk I, Dolenc I, Turk D, Cimerman N, Kos J, Colic A, Stoka V, Turk V.
    Biol Chem Hoppe Seyler; 1995 Apr; 376(4):225-30. PubMed ID: 7626231
    [Abstract] [Full Text] [Related]

  • 24. Lysosomal proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer.
    Kos J, Smid A, Krasovec M, Svetic B, Lenarcic B, Vrhovec I, Skrk J, Turk V.
    Biol Chem Hoppe Seyler; 1995 Jul; 376(7):401-5. PubMed ID: 7576236
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Elongation on the amino-terminal part of stefin B decreases inhibition of cathepsin H.
    Jerala R, Kroon-Zitko L, Popovic T, Turk V.
    Eur J Biochem; 1994 Sep 15; 224(3):797-802. PubMed ID: 7925405
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Kinetics of the pH-induced inactivation of human cathepsin L.
    Turk B, Dolenc I, Turk V, Bieth JG.
    Biochemistry; 1993 Jan 12; 32(1):375-80. PubMed ID: 7678196
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Structural basis for different inhibitory specificities of human cystatins C and D.
    Hall A, Ekiel I, Mason RW, Kasprzykowski F, Grubb A, Abrahamson M.
    Biochemistry; 1998 Mar 24; 37(12):4071-9. PubMed ID: 9521728
    [Abstract] [Full Text] [Related]

  • 34. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.
    Krepela E, Procházka J, Kárová B, Cermák J, Roubková H.
    Neoplasma; 1998 Mar 24; 45(5):318-31. PubMed ID: 9921922
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L.
    Estrada S, Nycander M, Hill NJ, Craven CJ, Waltho JP, Björk I.
    Biochemistry; 1998 May 19; 37(20):7551-60. PubMed ID: 9585570
    [Abstract] [Full Text] [Related]

  • 39. Differences in specificity for the interactions of stefins A, B and D with cysteine proteinases.
    Lenarcic B, Krizaj I, Zunec P, Turk V.
    FEBS Lett; 1996 Oct 21; 395(2-3):113-8. PubMed ID: 8898076
    [Abstract] [Full Text] [Related]

  • 40. Human cathepsin X. A novel cysteine protease with unique specificity.
    Ménard R, Nägler DK, Zhang R, Tam W, Sulea T, Purisima EO.
    Adv Exp Med Biol; 2000 Oct 21; 477():317-22. PubMed ID: 10849759
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.